Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al

被引：0
|
作者：
Mathian, Alexis [1 ]
Amoura, Zahir [1 ]
机构：
[1] Sorbonne Univ, Groupement Hosp Pitie Salpetriere, AP HP,French Natl Referral Ctr System Lupus Eryth, Serv Med Interne 2,Inst E3M,Inserm,UMRS,Ctr Immun, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷 / 05期
关键词：
lupus erythematosus; systemic; hydroxychloroquine; autoimmune diseases;
D O I：
10.1136/annrheumdis-2020-218176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
    Fernandez-Ruiz, Ruth
    Paredes, Jacqueline L.
    Niewold, Timothy B.
    TRANSLATIONAL RESEARCH, 2021, 232 : 13 - 36
  • [22] The Role of Immunosuppression in the Development of COVID-19 in Systemic Lupus Erythematosus Patients: A Brief Report
    Abdolahi, Nafiseh
    Damirchi, Mohammadrafi
    Aghaie, Mehrdad
    Sedighi, Sima
    Tavassoli, Samaneh
    Roshandel, Gholamreza
    Hassani, Mohammadjavad
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2023, 48 (01) : 91 - 97
  • [23] Systemic lupus erythematosus manifestation following COVID-19: a case report
    Batool Zamani
    Seyed-Masoud Moeini Taba
    Mohammad Shayestehpour
    Journal of Medical Case Reports, 15
  • [24] Systemic lupus erythematosus manifestation following COVID-19: a case report
    Zamani, Batool
    Taba, Seyed-Masoud Moeini
    Shayestehpour, Mohammad
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [25] Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus
    Yilmaz, Esra Karabag
    Agbas, Ayse
    Canpolat, Nur
    Gunalp, Aybuke
    Sahin, Sezgin
    Ozbey, Dogukan
    Gulmez, Ruveyda
    Saygili, Seha Kamil
    Kocazeybek, Bekir
    Kasapcopur, Ozgur
    Caliskan, Salim
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):
  • [26] Response to: 'Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?' by Chessa et al
    Askanase, Anca
    Oon, Shereen
    Huq, Molla
    Calderone, Alicia
    Morand, Eric F.
    Nikpour, Mandana
    Aranow, Cynthia
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05)
  • [27] Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic
    Chuah, Seow Lin
    Teh, Cheng Lay
    Wan Mohd Akbar, Sharifah Aishah
    Cheong, Yaw Kiet
    Sachdev Manjit Singh, Benjamin
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08)
  • [28] Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study
    Ran, Shu
    Pan, Lixin
    Liu, Baolin
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [29] Response to: ''2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus' by Aringer et al' by Cui et al
    Aringer, Martin
    Costenbader, Karen H.
    Doerner, Thomas
    Johnson, Sindhu R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (09) : e166
  • [30] Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al
    Fanouriakis, Antonis
    Kostopoulou, Myrto
    Bertsias, George
    Boumpas, Dimitrios T.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (10)
12345